Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan

Background and aims: We aimed to compare clinical outcomes and safety after sorafenib therapy between patients with Barcelona Clinic Liver Cancer (BCLC) stage B or C hepatocellular carcinoma (HCC) aged ≥75 years (aged group, n=179) and those with BCLC stage B or C HCC aged <75 years (control grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Hiroki, Takeda, Haruhiko, Tsuchiya, Kaoru, Joko, Kouji, Ogawa, Chikara, Taniguchi, Hiroyoshi, Orito, Etsuro, Uchida, Yasushi, Osaki, Yukio, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067509/
https://www.ncbi.nlm.nih.gov/pubmed/24963354
http://dx.doi.org/10.7150/jca.9257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067509/
https://www.ncbi.nlm.nih.gov/pubmed/24963354
http://dx.doi.org/10.7150/jca.9257

Ejemplares similares